» Articles » PMID: 22201124

Cdc6 Expression Represses E-cadherin Transcription and Activates Adjacent Replication Origins

Abstract

E-cadherin (CDH1) loss occurs frequently in carcinogenesis, contributing to invasion and metastasis. We observed that mouse and human epithelial cell lines overexpressing the replication licensing factor Cdc6 underwent phenotypic changes with mesenchymal features and loss of E-cadherin. Analysis in various types of human cancer revealed a strong correlation between increased Cdc6 expression and reduced E-cadherin levels. Prompted by these findings, we discovered that Cdc6 repressed CDH1 transcription by binding to the E-boxes of its promoter, leading to dissociation of the chromosomal insulator CTCF, displacement of the histone variant H2A.Z, and promoter heterochromatinization. Mutational analysis identified the Walker B motif and C-terminal region of Cdc6 as essential for CDH1 transcriptional suppression. Strikingly, CTCF displacement resulted in activation of adjacent origins of replication. These data demonstrate that Cdc6 acts as a molecular switch at the E-cadherin locus, linking transcriptional repression to activation of replication, and provide a telling example of how replication licensing factors could usurp alternative programs to fulfill distinct cellular functions.

Citing Articles

Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC.

Li C, Zhang E, Yu R, Yuan B, Yang Y, Zeng Z Transl Oncol. 2025; 53:102314.

PMID: 39904279 PMC: 11846587. DOI: 10.1016/j.tranon.2025.102314.


Exploring the role of exosomal MicroRNAs as potential biomarkers in preeclampsia.

Shan Y, Hou B, Wang J, Chen A, Liu S Front Immunol. 2024; 15:1385950.

PMID: 38566996 PMC: 10985148. DOI: 10.3389/fimmu.2024.1385950.


CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.

Shen M, Zhang Y, Tang L, Fu Q, Zhang J, Xu Y BMC Cancer. 2023; 23(1):978.

PMID: 37833632 PMC: 10571299. DOI: 10.1186/s12885-023-11186-6.


G1 Dynamics at the Crossroads of Pluripotency and Cancer.

Fleifel D, Cook J Cancers (Basel). 2023; 15(18).

PMID: 37760529 PMC: 10526231. DOI: 10.3390/cancers15184559.


A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer.

Mourkioti I, Polyzou A, Veroutis D, Theocharous G, Lagopati N, Gentile E J Exp Clin Cancer Res. 2023; 42(1):187.

PMID: 37507762 PMC: 10386253. DOI: 10.1186/s13046-023-02769-z.


References
1.
Trougakos I, Margaritis L . The formation of the functional chorion structure of Drosophila virilis involves inercalation of the "middle" and "late" major chorion proteins: a general model for chorion assembly in Drosophilidae. J Struct Biol. 1999; 123(2):97-110. DOI: 10.1006/jsbi.1998.4999. View

2.
Blow J, Gillespie P . Replication licensing and cancer--a fatal entanglement?. Nat Rev Cancer. 2008; 8(10):799-806. PMC: 2577763. DOI: 10.1038/nrc2500. View

3.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

4.
Antequera F . Genomic specification and epigenetic regulation of eukaryotic DNA replication origins. EMBO J. 2004; 23(22):4365-70. PMC: 526466. DOI: 10.1038/sj.emboj.7600450. View

5.
Negrini S, Gorgoulis V, Halazonetis T . Genomic instability--an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010; 11(3):220-8. DOI: 10.1038/nrm2858. View